GeminIQ Website Logo

Viewing LFMD free

Subscribe for full history, 50+ metrics, screener, watchlist...

LifeMD, Inc.

LFMD

Companies in Services-Offices & Clinics of Doctors of Medicine

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
34-24363435383635331512
Accounts Receivable Net Current
109971010665544
Deposits Assets Current
000000000000
Inventory Net
333333322344
Other Assets Current
434223221111
Assets Current
525241495052494544432520
Assets Noncurrent
Property Plant And Equipment Net
223211111000
Operating Lease Right Of Use Asset
556666732111
Capitalized Computer Software Net
11111515149131312121110
Finite Lived Intangible Assets Net
002220233334
Assets Noncurrent
181925252424241917161615
Assets
707066747476736461584135
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
221420241611161512111010
Accrued Liabilities Current
151622151922211515141515
Notes Payable Current
-------00001
Operating Lease Liability Current
111100000111
Deferred Revenue
-----------6
Convertible Debt Current
---12128564---
Deferred Revenue Current
121114121717211513966
Liabilities Current
504257646167595245353332
Long Term Debt Noncurrent
Convertible Debt Noncurrent
---4710131214181914
Operating Lease Liability Noncurrent
666666721000
Business Combination Contingent Consideration Liab…
--0000000000
Liabilities
554763737484796660535246
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…
-----------5
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
253251249236233231227225221218197187
Retained Earnings Accumulated Deficit
-238-229-248-238-236-240-235-229-222-214-210-203
Treasury Stock Value
-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity
15231-2-5-8-8-4-16-11-16
Minority Interest
--2222222221
Liabilities And Stockholders Equity
707066747476736461584135
Temporary Equity Par Or Stated Value Per Share
---000000000
Temporary Equity Shares Authorized
---555555555
Preferred Stock Par Or Stated Value Per Share
000000--0000
Preferred Stock Shares Authorized
555555--5555
Preferred Stock Liquidation Preference
00---0------
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
100100100100100100100100100100100100
Common Stock Shares Issued
14314014013513112712612512211510498
Shares Outstanding
14314014013513112712512512211510497
Treasury Stock Common Shares
000000000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-18.79%-21.63%-29.60%---------
202557.35%77.19%37.76%-47.72%-45.69%-46.79%-28.12%-18.39%-33.62%-10.23%27.88%9.46%
2024-33.09%-44.36%-42.98%-2.98%-2.98%-20.11%28.46%1.75%0.00%-7.53%29.93%118.82%
202316.94%137.70%149.18%16.12%70.77%72.68%8.38%15.78%-18.02%20.50%57.36%3.77%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.04
1.25
0.73
0.77
0.82
0.78
0.83
0.87
0.99
1.22
0.77
0.64
Quick Ratio
0.98
1.18
0.66
0.72
0.77
0.74
0.78
0.83
0.94
1.15
0.65
0.52
Working Capital
2.11M
10.26M
-15.58M
-14.51M
-10.93M
-15.03M
-10.30M
-6.58M
-266.33K
7.82M
-7.64M
-11.34M
Leverage & Debt
Debt to Equity
3.66
2.04
47.64
-41.05
-13.53
-11.07
-10.17
-15.66
-71.17
9.51
-4.67
-2.85
Interest Coverage TTM
-15.26
-5.41
-4.00
-4.37
-7.13
-9.38
-8.51
-8.19
-6.34
-5.58
-8.05
-11.26
Debt Ratio
0.79
0.67
0.95
0.99
1.01
1.10
1.08
1.03
0.98
0.90
1.27
1.29
Efficiency & Turnover
Asset Turnover TTM
2.69
2.65
2.60
2.52
2.39
2.30
3.41
3.59
3.43
3.63
3.67
3.50
Days Sales Outstanding TTM
18.92
18.58
15.50
13.70
17.54
18.55
9.90
9.56
9.23
9.70
9.35
8.77
Receivables Turnover TTM
19.29
19.64
23.54
26.64
20.81
19.68
36.86
38.19
39.54
37.61
39.04
41.61
Per Share Metrics
Diluted EPS TTM
0.14
0.35
-0.16
-0.19
-0.32
-0.51
-0.61
-0.64
-0.69
-0.70
-0.91
-1.02
Free Cash Flow Per Share TTM
0.08
0.14
0.23
0.40
0.32
0.39
0.49
0.38
0.42
0.25
0.03
-0.09
Dividend Per Share TTM
0.07
0.07
0.07
0.07
0.07
0.08
0.07
0.08
0.08
0.09
0.09
0.10
Margin Metrics
Gross Profit Margin TTM
86.81%
85.72%
83.46%
84.18%
84.54%
86.15%
89.64%
88.92%
88.21%
87.61%
87.03%
86.36%
Operating Profit Margin TTM
-7.97%
-3.95%
-4.44%
-5.78%
-9.54%
-13.18%
-9.66%
-10.78%
-10.89%
-9.50%
-16.71%
-19.58%
Net Profit Margin TTM
3.31%
8.05%
-4.23%
-4.97%
-8.58%
-13.47%
-13.34%
-14.72%
-16.45%
-15.54%
-23.13%
-25.91%
Growth Metrics
Net Revenue Growth (1Y)
19.66%
25.34%
-6.69%
-2.89%
-1.22%
1.49%
42.07%
38.63%
32.85%
28.15%
14.77%
14.96%
Net Income Growth (1Y)
-146.16%
-174.88%
-70.42%
-67.24%
-48.48%
-11.99%
-18.04%
-21.26%
-30.62%
-51.27%
-39.30%
-43.42%
EPS Growth (1Y)
-142.06%
-168.35%
-73.07%
-69.53%
-53.13%
-27.57%
-32.76%
-37.92%
-43.99%
-55.48%
-45.53%
-46.47%
Valuation Metrics
P/E TTM
26.70
9.85
-41.16
-70.35
-16.93
-9.78
-8.55
-10.80
-14.99
-11.86
-6.86
-4.25
P/B TTM
11.36
6.65
238.48
-339.26
-42.90
-26.99
-28.52
-67.35
-477.24
50.50
-19.44
-8.84
P/S TTM
0.88
0.79
1.74
3.49
1.45
1.32
1.14
1.59
2.47
1.84
1.59
1.10
Market Cap
170.88M
153.89M
313.44M
604.75M
234.66M
203.92M
220.19M
283.29M
403.41M
281.07M
215.46M
141.64M
Enterprise Value
136.41M
153.89M
289.66M
584.00M
221.14M
187.25M
200.83M
265.73M
386.44M
266.18M
219.42M
144.00M
Calculated Values
Free Cash Flow TTM
3.80M
6.41M
10.72M
17.92M
13.97M
16.05M
20.78M
15.57M
16.29M
8.62M
1.03M
-2.81M
Net Debt
-34.48M
0.00
-23.79M
-20.75M
-13.52M
-16.68M
-19.36M
-17.56M
-16.97M
-14.89M
3.97M
2.37M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-12-09Sale
Owner: Friedeman, Jessica
Title: Chief Marketing Officer
Shares: 15,000
Price/Share: $3.61
Value: $54,150.00
Shares Owned: 205,000
Relationship: Officer
Ownership: Direct
2025-09-10Sale
Owner: Alvarez, Nicholas P
Title: Chief Acquisition Officer
Shares: 75,000
Price/Share: $5.92
Value: $444,000.00
Shares Owned: 605,000
Relationship: Officer
Ownership: Direct
2025-07-01Sale
Owner: Schreiber, Justin
Title: Chairman and CEO
Shares: 25,000
Price/Share: $9.99
Value: $249,750.00
Shares Owned: 2,475,721
Relationship: Director,Officer
Ownership: Indirect
2025-06-17Sale
Owner: Benathen, Marc David
Title: Chief Financial Officer
Shares: 50,000
Price/Share: $14.01
Value: $700,500.00
Shares Owned: 339,554
Relationship: Officer
Ownership: Direct
2025-06-13Sale
Owner: Galluppi, Stefan
Title: Chief Innovation Officer
Shares: 85,000
Price/Share: $12.38
Value: $1,052,300.00
Shares Owned: 80,449
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
37.38%
Inst. Shares: 17,694,902
Shares Outstanding: 47,336,060
2025-12-31
41.58%
Inst. Shares: 18,762,755
Shares Outstanding: 45,129,617
2025-09-30
42.82%
Inst. Shares: 19,767,415
Shares Outstanding: 46,162,625
2025-06-30
52.06%
Inst. Shares: 23,116,447
Shares Outstanding: 44,401,531
2025-03-31
37.63%
Inst. Shares: 16,233,040
Shares Outstanding: 43,135,778

LifeMD, Inc. (LFMD) — SEC Financial Statements & Analysis

LifeMD, Inc. (LFMD) is a services-offices & clinics of doctors of medicine company, incorporated in DE. LifeMD, Inc. trades on LFMDP: Nasdaq as: LFMD: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), LifeMD, Inc. reported a 19.66% year-over-year revenue growth, a Gross Profit Margin of 86.81% (TTM), a Debt-to-Equity ratio of 3.66x, a Price-to-Sales (P/S) ratio of 0.88x (TTM), a Price-to-Book (P/B) ratio of 11.36 (TTM), at a market cap of $170.88M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
19.66%
Gross Profit Margin TTM
86.81%
Debt To Equity
3.66x
P/S TTM
0.88x
P/B TTM
11.36
Market Cap
$170.88M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LifeMD, Inc. in?

LifeMD, Inc. (LFMD) operates in the Services-Offices & Clinics of Doctors of Medicine industry.

What is LFMD's market cap?

LifeMD, Inc. (LFMD) has a market capitalization of $170.88M as of 2026-03-31.

What is LFMD's P/E ratio?

LifeMD, Inc. (LFMD)'s trailing twelve month P/E ratio is 26.70x as of 2026-03-31.

What exchange does LFMD trade on?

LifeMD, Inc. (LFMD) trades on the LFMDP: Nasdaq.

Where is LifeMD, Inc. incorporated?

LifeMD, Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

LifeMD, Inc. (LFMD) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.